Navigation Links
CHIPSA Hospital Files Patent on Cancer Immunotherapy Combination of Checkpoint Inhibitors and Coley Vaccine
Date:9/15/2017

Preclinical and clinical data support efficacy of novel approach to cancer immunotherapy developed by CHIPSA hospital.

CHIPSA Hospital, dedicated to the accelerated development of nontoxic cancer immunotherapies announced today filing of a patent application covering the combination of FDA approved antibodies known as “checkpoint inhibitors” together with Coley Vaccine, a stimulatory of innate immunity. CHIPSA is the only licensed hospital facility (under doctor supervision) treating with the Coley’s Vaccine in North America.  The patent was based on animal data using the established B16 melanoma mouse model, as well as patient cases.

“CHIPSA is one of the oldest hospitals to be using Coley’s Vaccine therapy.  Our experiences and published literature suggests that Coley’s Vaccine is one of the most potent activators of the innate immune system[1],[2].  Given that cellular components of the innate immune system such as macrophage and dendritic cells play a fundamental role in the visibility of cancer to the immune system, we believe that activating these cells with Coley’s will increase responsiveness to checkpoint inhibitors.  This belief is supported by animal experiments and pilot human studies.” Said Edward Clay, Former CEO of CHIPSA Hospital and now Chief Executive of United Cancer Centers, as well as coinventor of the patent.

Currently, only about 20% of patients with advanced cancer respond to checkpoint inhibitors.  Data generated by CHIPSA collaborators and published data suggests that stimulating the innate immune system makes tumors more visible to the adaptive immune system, thus potentially increasing the number of patients responding to checkpoint inhibitors.

“The immunology behind this combined approach, which yielded synergistic antitumor effects, is very interesting in that checkpoint inhibitors, such as Yervoy, Keytruda, and Opdivo act to stimulate the adaptive part of the immune system, whereas Coley’s Vaccine activates the innate arm of the immune system.  Classical immunology teaches us that the innate and adaptive arms of the immune system work in synergy.  By concurrent activation of both of these arms of the immune system, we believe we are driving the immune system into a state of overdrive, thus overcoming tumor associated immune suppression and increasing probability of remission.” Said Dr. Thomas Ichim, coinventor of the patent.

“I am proud to have led the clinical implementation of combining Coley’s Vaccine, which has been used for more than 100 years, with cutting edge immunological treatments like checkpoint inhibitors.  The filing of today’s patent, is testimony to how here at CHIPSA we go the extra mile to offer the most advanced medicines to our patients.” Said Dr. Stephen Iacaboni, an Award Winning former MD Anderson Oncologist, who along with the other doctors at CHIPSA, performed the first combination therapies of Coley’s Vaccine with Checkpoint Inhibitors.

About CHIPSA

CHIPSA (Centro Hospitalario Internacional del Pacifico, S.A.) is a full service hospital caring for families with sick and injured within the ocean-front suburb of Playas de Tijuana.  Since inception in 1979, CHIPSA Gerson integrative medical practice has become world renown and has been long identified as the home of Mexico’ Center for Integrative Medicine and Research. Our founding legacy, Gerson Therapy, represents the original medical practice of immuno-nutrition therapy developed by Max B. Gerson, M.D. (founder of immune-nutrition) known for his many contributions to address chronic, degenerative and infectious disease, as well as the documentation and remission of cancer.

Contacts 

info(at)chipsahospital(dot)org

1-855-624-4772

Patient Inquiries

http://www.chipsahospital.org

1-855-624-4772

[1] Jessy T. Immunity over inability: The spontaneous regression of cancer. J Nat Sci Biol Med. 2011 Jan;2(1):43-9. [2 Maletzki et al. Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's Toxin.  Clin Dev Immunol. 2012;2012:230625 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502841/

Read the full story at http://www.prweb.com/releases/2017/09/prweb14701489.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Martin General Hospital Partners with Specialists On Call to Offer Critical Care Services
2. BC Children’s Hospital Orthopaedic team creating first-ever global hip dysplasia registry and standardized assessment tool to benefit children worldwide
3. Joe DiMaggio Children’s Hospital Launches National Podcast Focused on Health and Parenting
4. First Texas Hospital and 28 First Choice Emergency Room Facilities Across Houston are Open and Operating 24/7 Post-Harvey
5. First Texas Hospital and 26 First Choice Emergency Room Facilities Across Houston are Open and Operating 24/7 Post-Harvey
6. 24/7 Intensive Care Unit Technology Comes to Florida Hospital Zephyrhills
7. Boston Strategic Partners, Inc. is utilizing Electronic Health Record Data to analyze hospital treated sepsis
8. T-System Offers Disaster Relief T Sheets Free of Charge to Hospitals Impacted by Hurricane Harvey
9. Hospitals Team Up to Fight Northeast Ohio Opioid Epidemic
10. US News & World Report’s High Performing Hospitals Ranks Arizona Spine & Joint for Knee Replacement
11. Allegheny Health Network’s Chief Nurse Executive Named to American Hospital Association Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2018)... ... October 16, 2018 , ... 13th Annual FDA Inspections Summit ... , The 13th Annual FDA Inspections Summit starts in one week. , So ... to keep up. The FDA is focused on any number of new topics: ...
(Date:10/16/2018)... CUMBERLAND FORESIDE, Maine (PRWEB) , ... October 15, ... ... innovative Body Fluids product line, VALIDATE® Body Fluids, Order Number 205bf, for easier ... matrix, will assist in the documentation of linearity, calibration verification and verification of ...
(Date:10/16/2018)... LOS ANGELES (PRWEB) , ... October 16, 2018 ... ... conference announced today that it will host the proceedings of the 4th Annual ... speak at this symposium that runs Wednesday, May 22, 2019, through Friday, May ...
(Date:10/13/2018)... ... , ... At HEI Health, we believe tomorrow’s healthcare can be made affordable ... Healthcare CXO Fall Summit by Marcus Evans. HEI will be hosting an exclusive round ... with leading healthcare providers. , Marcus Evans National Healthcare CXO Summit is the ...
(Date:10/13/2018)... (PRWEB) , ... October 12, 2018 , ... Convoy of ... communities. Convoy of Hope has a distribution site set up to serve hurricane survivors ... , Up to 50 additional truckloads of supplies are in ...
Breaking Medicine News(10 mins):
(Date:10/18/2018)... ... October 18, 2018 , ... On October 24th, Harlem United, ... years of service to New Yorkers with its 2018 Boulevard Bash Gala at ... , Harlem United will honor Soledad O’Brien with the Community Champion Award in ...
(Date:10/18/2018)... ... 18, 2018 , ... As parts of Florida are still ... Medical Center, Tel HaShomer are traveling to South Florida to teach emergency response ... to manage and respond to large-scale emergencies. This will help first responders and ...
(Date:10/17/2018)... ... 2018 , ... Dr. Dan Holtzclaw, Chief Clinical Officer of ... of placental based growth factors for the treatment of nerve injuries related to ... Dental Implant Center locations in Austin and San Antonio, we occasionally see patients ...
Breaking Medicine Technology: